Apollon Wealth Management LLC Has $3.42 Million Position in HCA Healthcare, Inc. $HCA

Apollon Wealth Management LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 32.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,216 shares of the company’s stock after buying an additional 1,781 shares during the quarter. Apollon Wealth Management LLC’s holdings in HCA Healthcare were worth $3,415,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp boosted its position in HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares during the last quarter. Capital World Investors increased its holdings in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares during the last quarter. Geode Capital Management LLC lifted its stake in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after acquiring an additional 13,565 shares during the last quarter. Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter valued at $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Royal Bank Of Canada reduced their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. JPMorgan Chase & Co. reduced their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Stephens lowered their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. TD Cowen decreased their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Finally, Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $390.10 on Wednesday. The firm has a fifty day moving average price of $404.81 and a two-hundred day moving average price of $463.96. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a market cap of $86.54 billion, a PE ratio of 13.41, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.